OGG1
Basic information
Region (hg38): 3:9749944-9788219
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OGG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 27 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 14 | 15 | ||||
Total | 0 | 0 | 34 | 9 | 1 |
Variants in OGG1
This is a list of pathogenic ClinVar variants found in the OGG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-9750414-A-T | not specified | Uncertain significance (Aug 17, 2021) | ||
3-9750416-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
3-9750423-G-A | Clear cell carcinoma of kidney | Uncertain significance (Jul 31, 2021) | ||
3-9750981-A-T | OGG1-related disorder | Likely benign (Sep 05, 2019) | ||
3-9751003-C-G | not specified | Uncertain significance (Apr 08, 2023) | ||
3-9751012-A-G | not specified | Uncertain significance (May 30, 2024) | ||
3-9751100-A-G | not specified | Uncertain significance (Jul 20, 2021) | ||
3-9751135-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
3-9751138-C-T | not specified | Uncertain significance (May 16, 2022) | ||
3-9751159-T-C | not specified | Likely benign (Apr 12, 2022) | ||
3-9751785-G-T | not specified | Uncertain significance (Aug 24, 2023) | ||
3-9751790-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
3-9751830-A-G | Uncertain significance (Sep 24, 2021) | |||
3-9751913-A-T | not specified | Uncertain significance (Jun 23, 2021) | ||
3-9754716-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
3-9754784-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
3-9756462-C-T | OGG1-related disorder | Likely benign (Dec 09, 2019) | ||
3-9756522-G-T | not specified | Uncertain significance (Mar 21, 2023) | ||
3-9756779-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
3-9756791-G-A | OGG1-related disorder | Likely benign (Mar 01, 2023) | ||
3-9756823-G-A | Likely benign (May 11, 2018) | |||
3-9757056-T-C | OGG1-related disorder | Benign (Mar 29, 2018) | ||
3-9757089-C-G | OGG1-related disorder | Benign (Oct 17, 2019) | ||
3-9757095-A-G | not specified | Likely benign (Nov 07, 2022) | ||
3-9757096-T-C | OGG1-related disorder | Likely benign (Mar 11, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OGG1 | protein_coding | protein_coding | ENST00000302036 | 7 | 38276 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.93e-12 | 0.0928 | 125689 | 0 | 59 | 125748 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.572 | 271 | 246 | 1.10 | 0.0000139 | 2715 |
Missense in Polyphen | 72 | 67.55 | 1.0659 | 775 | ||
Synonymous | -1.21 | 115 | 99.6 | 1.15 | 0.00000545 | 894 |
Loss of Function | 0.493 | 19 | 21.5 | 0.885 | 0.00000134 | 181 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000757 | 0.000756 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000177 | 0.000176 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.000556 | 0.000555 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: DNA repair enzyme that incises DNA at 8-oxoG residues. Excises 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N- methylformamidopyrimidine (FAPY) from damaged DNA. Has a beta- lyase activity that nicks DNA 3' to the lesion.;
- Pathway
- Base excision repair - Homo sapiens (human);DNA Repair;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Depurination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Base Excision Repair;Validated transcriptional targets of TAp63 isoforms;Displacement of DNA glycosylase by APEX1;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
(Consensus)
Recessive Scores
- pRec
- 0.466
Intolerance Scores
- loftool
- 0.557
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.73
Haploinsufficiency Scores
- pHI
- 0.265
- hipred
- N
- hipred_score
- 0.438
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ogg1
- Phenotype
- neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- ogg1
- Affected structure
- cardiac muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- acute inflammatory response;base-excision repair;base-excision repair, AP site formation;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;response to oxidative stress;aging;response to radiation;response to light stimulus;response to estradiol;nucleotide-excision repair, DNA incision;negative regulation of apoptotic process;depurination;depyrimidination;response to ethanol;response to folic acid;cellular response to cadmium ion;negative regulation of double-strand break repair via single-strand annealing
- Cellular component
- nucleus;nucleoplasm;mitochondrion;nuclear matrix;nuclear speck;protein-containing complex
- Molecular function
- damaged DNA binding;endonuclease activity;protein binding;microtubule binding;oxidized purine nucleobase lesion DNA N-glycosylase activity;oxidized purine DNA binding;8-oxo-7,8-dihydroguanine DNA N-glycosylase activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity